The Centers for Disease Control and Prevention (CDC) on Monday warned that a deadly fungus called Candida auris (C. auris) is spreading at an "alarming rate" in the U.S. healthcare facilities. 

“The rapid rise and geographic spread of cases is concerning and emphasizes the need for continued surveillance, expanded lab capacity, quicker diagnostic tests, and adherence to proven infection prevention and control,” said CDC epidemiologist Dr. Meghan Lyman, lead author of the paper, in a press release. 

Adding to the agency's concerns, the number of infections that were resistant to echinocandins, which is the antifungal medicine most commonly used to treat C. auris infections, tripled in 2021. 

The CDC classified C. auris as an "urgent antimicrobial resistance (AR) threat," meaning "it is often resistant to multiple antifungal drugs, spreads easily in healthcare facilities, and can cause severe infections with high death rates."

Between 2016, when C. auris was first reported, and 2021, there have been a total of 3,270 clinical cases reported and 7,413 screening cases. 

The agency said "poor general infection prevention and control (IPC) practices in healthcare facilities" are responsible for the spread. However, expanded efforts to detect cases is also responsible for the jump in reported cases.

Share:
More In Science
Why Turkey's Ship Breaking Business Is Booming
Turkey’s shipbreaking yard is located in the town of Aliaga - about 30 miles north of Port Izmir. Usually, this yard breaks down cargo and container ships. But in 2020, it started bringing in another type of vessel. And business is booming.
Disneyland Opening Highlights California's COVID Turnaround
Disneyland has reopened after a 13-month closure. The iconic theme park in Southern California that was closed under the state's strict virus rules swung open its gates Friday and some visitors came in cheering and screaming with happiness.
Load More